RT Journal Article
SR Electronic
T1 Olfactory and Gustatory Dysfunction as An Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.13.20100198
DO 10.1101/2020.05.13.20100198
A1 Qiu, Chenghao
A1 Cui, Chong
A1 Hautefort, Charlotte
A1 Haehner, Antje
A1 Zhao, Jun
A1 Yao, Qi
A1 Zeng, Hui
A1 Nisenbaum, Eric J.
A1 Liu, Li
A1 Zhao, Yu
A1 Zhang, Di
A1 Levine, Corinna G.
A1 Cejas, Ivette
A1 Dai, Qi
A1 Zeng, Mei
A1 Herman, Philippe
A1 Jourdaine, Clement
A1 de With, Katja
A1 Draf, Julia
A1 Chen, Bing
A1 Jayaweera, Dushyantha T.
A1 Denneny, James C.
A1 Casiano, Roy
A1 Yu, Hongmeng
A1 Eshraghi, Adrien A.
A1 Hummel, Thomas
A1 Liu, Xuezhong
A1 Shu, Yilai
A1 Lu, Hongzhou
YR 2020
UL http://medrxiv.org/content/early/2020/05/16/2020.05.13.20100198.abstract
AB Objective Evaluate the prevalence and characteristics of olfactory or gustatory dysfunction in COVID-19 patientsStudy Design Multicenter Case SeriesSetting 5 tertiary care hospitals (3 in China, 1 in France, 1 in Germany)Subjects and Methods 394 PCR confirmed COVID-19 positive patients were screened, and those with olfactory or gustatory dysfunction were included. Data including demographics, COVID-19 severity, patient outcome, and the incidence and degree of olfactory and/or gustatory dysfunction were collected and analyzed. The Questionnaire of Olfactory Disorders (QOD) and Visual Analogue Scale (VAS) were used to quantify olfactory and gustatory dysfunction respectively. All subjects at one hospital (Shanghai) without subjective olfactory complaints underwent objective testing.Results Of 394 screened subjects, 161 (41%) reported olfactory and/or gustatory dysfunction and were included. Incidence of olfactory and/or gustatory disorders in Chinese (n=239), German (n=39) and French (n=116) cohorts were 32%, 69%, and 49% respectively. The median age of included subjects was 39 years old, 92/161 (57%) were male, and 10/161 (6%) were children. Of included subjects, 10% had only olfactory or gustatory symptoms, and 19% had olfactory and/or gustatory complaints prior to any other COVID-19 symptom. Of subjects with objective olfactory testing, 10/90 demonstrated abnormal chemosensory function despite reporting normal subjective olfaction. 43% (44/102) of subjects with follow-up showed symptomatic improvement in olfaction or gustation.Conclusions Olfactory and/or gustatory disorders may represent early or isolated symptoms of SARS-CoV-2 infection. They may serve as a useful additional screening criterion, particularly for the identification of patients in the early stages of infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by National Natural Science Foundation of China (No. 81822011, 81771013)and University of Miami COVID-19 Rapid Response Grant (UM 2020-2227)Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data for the present study are available from the corresponding author upon reasonable request.